Odyssey Therapeutics, Inc. ODTX
18.34 USD -0.64 (-3.37%)
Regular-session close
18.34 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
18.19 Day range 19.25
15.10 52-week range 29.05
- YTD
- +11.69%
- 1 year
- +11.69%
Ownership
- Institutions 86.0%
- Insiders 6.19%
- Public and other holders 7.86%
Held by insiders 6.19%
Held by institutions 85.96%
Float held by institutions 91.63%
Institutions 88
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 12.98% | 6,239,237 | 130.96M | Sep 29, 2026 |
| SR One Capital Management, LP | 7.89% | 3,794,883 | 79.65M | Jun 29, 2026 |
| TPG GP A, LLC | 7.68% | 3,690,146 | 77.46M | Jun 29, 2026 |
| Lightspeed Management Company, L.L.C. | 7.51% | 3,608,443 | 75.74M | Jun 29, 2026 |
| Orbimed Advisors LLC. | 6.24% | 3,001,198 | 63.00M | Jun 29, 2026 |
| Sanofi | 4.14% | 1,990,200 | 41.77M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.45% | 1,175,634 | 24.68M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.10% | 531,096 | 11.15M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.88% | 424,684 | 8.91M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.73% | 349,200 | 7.33M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 0.68% | 329,062 | 6.91M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 0.59% | 284,000 | 5.96M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHU SHELLEY | Director | Purchase | May 10, 2026 | 11,111 |
| DIMENSION CAPITAL II, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 7, 2026 | 0 |
| GLICK GARY D. PH.D. | Chief Executive Officer | Conversion of Exercise of derivative security | May 10, 2026 | 415,973 |
| HAAS JASON | Chief Financial Officer | Purchase | May 7, 2026 | 62,908 |
| LEIDEN JEFFREY M | Director | Conversion of Exercise of derivative security | May 10, 2026 | 0 |
| LI NAN LN | Director | Purchase | May 10, 2026 | 0 |
